Pedro Zubizarreta

1.4k total citations
59 papers, 986 citations indexed

About

Pedro Zubizarreta is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Pedro Zubizarreta has authored 59 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Public Health, Environmental and Occupational Health and 17 papers in Hematology. Recurrent topics in Pedro Zubizarreta's work include Acute Lymphoblastic Leukemia research (20 papers), Acute Myeloid Leukemia Research (17 papers) and Neutropenia and Cancer Infections (12 papers). Pedro Zubizarreta is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), Acute Myeloid Leukemia Research (17 papers) and Neutropenia and Cancer Infections (12 papers). Pedro Zubizarreta collaborates with scholars based in Argentina, United States and United Kingdom. Pedro Zubizarreta's co-authors include Marı́a Sara Felice, Federico Sackmann‐Muriel, Hugo Paganini, Marta S. Gallego, Elizabeth M. Alfaro, Jorge G. Rossi, Myriam Guitter, Lidia Casimir, Roberto Debbag and Guillermo Chantada and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Pedro Zubizarreta

56 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Zubizarreta Argentina 18 437 320 264 181 164 59 986
Christine Bender‐Götze Germany 11 184 0.4× 256 0.8× 620 2.3× 64 0.4× 190 1.2× 15 999
Franz‐Martin Fink Austria 15 245 0.6× 180 0.6× 216 0.8× 20 0.1× 136 0.8× 31 845
A Lüthy Switzerland 13 302 0.7× 70 0.2× 79 0.3× 108 0.6× 85 0.5× 32 691
Taru Kuittinen Finland 18 390 0.9× 86 0.3× 468 1.8× 63 0.3× 38 0.2× 44 817
J.F. Seymour Australia 17 372 0.9× 79 0.2× 250 0.9× 23 0.1× 60 0.4× 52 1.1k
A Feldges Switzerland 13 160 0.4× 575 1.8× 348 1.3× 19 0.1× 432 2.6× 30 1.0k
Michael L. Graham United States 15 243 0.6× 144 0.5× 781 3.0× 11 0.1× 201 1.2× 32 1.3k
Maria Luisa Moleti Italy 16 225 0.5× 260 0.8× 251 1.0× 12 0.1× 150 0.9× 65 737
G. P. Tauro Australia 15 61 0.1× 254 0.8× 303 1.1× 34 0.2× 112 0.7× 26 711
Tushar Vora India 16 172 0.4× 95 0.3× 30 0.1× 28 0.2× 144 0.9× 85 772

Countries citing papers authored by Pedro Zubizarreta

Since Specialization
Citations

This map shows the geographic impact of Pedro Zubizarreta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Zubizarreta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Zubizarreta more than expected).

Fields of papers citing papers by Pedro Zubizarreta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Zubizarreta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Zubizarreta. The network helps show where Pedro Zubizarreta may publish in the future.

Co-authorship network of co-authors of Pedro Zubizarreta

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Zubizarreta. A scholar is included among the top collaborators of Pedro Zubizarreta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Zubizarreta. Pedro Zubizarreta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baroni, Lorena, et al.. (2023). Closing the gap: National Argentinian discussion forum on paediatric brain tumours. Frontiers in Oncology. 13. 1185766–1185766. 1 indexed citations
2.
Molina, Manuel, Sílvia Tenembaum, María Martha Katsicas, et al.. (2022). Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases. Frontiers in Pharmacology. 12. 785770–785770. 3 indexed citations
3.
Garrahan, Juan P., et al.. (2021). Carcinoma colorrectal en niños y adolescentes. Archivos Argentinos de Pediatria. 119(5).
4.
Mathey, D, et al.. (2021). Colorectal carcinoma in children and adolescents. Archivos Argentinos de Pediatria. 119(5). e487–e498. 11 indexed citations
5.
Baroni, Lorena, Claudia Sampor, Carlos Rugilo, et al.. (2021). Intracranial germ cells tumour: a single institution experience in Argentina. Journal of Neuro-Oncology. 152(2). 363–372. 7 indexed citations
6.
Zubizarreta, Pedro, et al.. (2020). Desmoid-type fibromatosis in children. Clinical features, treatment response, and long-term follow-up. PubMed. 80(5). 495–504. 2 indexed citations
7.
Rossi, Jorge G., Cristina N. Alonso, Patricia Rubio, et al.. (2020). No benefit of Interfant protocols compared to BFM‐based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina. Pediatric Blood & Cancer. 67(10). e28624–e28624. 2 indexed citations
8.
Rossi, Jorge G., Cristina N. Alonso, Myriam Guitter, et al.. (2018). Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome. Archivos Argentinos de Pediatria. 116(4). e500–e507. 7 indexed citations
9.
Galluzzo, Laura, et al.. (2018). Laparoscopic total nephrectomy for Wilms tumor: Towards new standards of care. Journal of Pediatric Urology. 14(5). 388–393. 12 indexed citations
10.
Zubizarreta, Pedro, et al.. (2017). Malignant extra-cranial germ cell tumors in children and adolescents. Results following the guidelines of SFOP/SFCE 95 Protocol.. PubMed. 76(5). 265–272. 2 indexed citations
11.
Rosé, Adriana, et al.. (2017). Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina. Journal of Pediatric Hematology/Oncology. 39(7). e349–e352. 11 indexed citations
12.
Zubizarreta, Pedro, et al.. (2017). Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy. Journal of Pediatric Hematology/Oncology. 39(8). 602–608. 9 indexed citations
13.
14.
Chantada, Guillermo, Ira J. Dunkel, Paula Schaiquevich, et al.. (2016). Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs. Journal of Global Oncology. 2(6). 347–352. 10 indexed citations
15.
Felice, Marı́a Sara, Marta S. Gallego, Cristina N. Alonso, et al.. (2011). Prognostic impact of t(1;19)/TCF3–PBX1in childhood acute lymphoblastic leukemia in the context of Berlin–Frankfurt–Münster-based protocols. Leukemia & lymphoma. 52(7). 1215–1221. 42 indexed citations
16.
Preciado, María Victoria, et al.. (2002). Epstein barr virus associated pediatric nasopharyngeal carcinoma: Its correlation with p53 and bcl‐2 expression. Medical and Pediatric Oncology. 38(5). 345–348. 7 indexed citations
17.
Paganini, Hugo, Pedro Zubizarreta, Antonio Latella, et al.. (2001). Criterios de bajo riesgo de mortalidad en niños con neutropenia y fiebre durante la quimioterapia por cancer. Medicina-buenos Aires. 2 indexed citations
18.
Paganini, Hugo, et al.. (2000). Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer. 88(12). 2848–2852. 69 indexed citations
19.
Zubizarreta, Pedro, Marı́a Sara Felice, Elizabeth M. Alfaro, et al.. (1998). Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy. Leukemia Research. 22(5). 465–472. 22 indexed citations
20.
Sackmann‐Muriel, Federico, Pedro Zubizarreta, Marı́a Sara Felice, et al.. (1996). Results of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemia. Leukemia Research. 20(11-12). 973–981. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Bender‐Götze Breakdown of academic impact, for papers by Franz‐Martin Fink Breakdown of academic impact, for papers by A Lüthy Breakdown of academic impact, for papers by Taru Kuittinen Breakdown of academic impact, for papers by J.F. Seymour Breakdown of academic impact, for papers by A Feldges Breakdown of academic impact, for papers by Michael L. Graham Breakdown of academic impact, for papers by Maria Luisa Moleti Breakdown of academic impact, for papers by G. P. Tauro Breakdown of academic impact, for papers by Tushar Vora
Rankless by CCL
2026